Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

384 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

NCT01519011

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Moores UCSD Cancer Center MC-0987 La Jolla, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
  • University of Cincinnati Physician's Inc. Cincinnati, Ohio, United States
View Trial Details
Completed

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

NCT00761722

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +26 more
Locations
  • California Cancer Care Inc Greenbrae, California, United States
  • Main Cancer Centers of Florida, P.A. Ocoee, Florida, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Completed

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

NCT00528983

Conditions
Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +16 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Central Indiana Cancer Centers Indianapolis, Indiana, United States
  • Kansas University Medical Center Westwood, Kansas, United States
View all 18 locations
View Trial Details
Completed

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00105001

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
View Trial Details
Completed

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

NCT00015951

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

NCT01305200

Conditions
Bone Marrow Diseases, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, +89 more
Locations
  • Children's Oncology Group Arcadia, California, United States
  • City of Hope Duarte, California, United States
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Rady Children's Hospital - San Diego San Diego, California, United States
View all 35 locations
View Trial Details

Related conditions